Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maine for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maine only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maine (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Chiara Battelli (NPI 1831398551)

Field	Value
Entity Type	Individual
Organization	Chiara Battelli
Address	11 Rock Row Ste 320
City	Westbrook
State	ME
ZIP	04092
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	July 12, 2007

Payer Source	Total Paid
Medicare	$301K
Medicaid	$0

Key Findings

This provider’s Medicare activity is concentrated in oncology infusion and supportive injection services: the top three Medicare codes (J0897, 99214, 96413) together account for 51.9% of total Medicare revenue, and the individual leading codes include J0897 (denosumab injection) at $73.4K and 96413 (chemotherapy infusion) at $24.9K, indicating active management of cancer patients and bone-health support in an outpatient infusion setting. Office E/M codes 99214 and 99215 also contribute meaningfully ($54.4K and $22.5K respectively), which underscores a blended model of infusion-based treatment plus ongoing clinic-based evaluation.

Revenue concentration is high: precomputed figures show the top three Medicare codes represent 51.9% of the provider’s Medicare revenue, with J0897 alone accounting for 25.0% of Medicare revenue ($73.4K). That concentration signals dependence on a small set of oncology-related drugs and E/M visits to drive the practice’s Medicare receipts, which could make revenue sensitive to changes in drug utilization or reimbursement for those specific codes.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $301K while there is no Medicaid billing on file. The absence of Medicaid activity suggests this provider’s public-payer exposure is concentrated in Medicare and that any analysis of payer strategy or risk should treat this provider as operating without a Medicaid revenue stream.

Competitive standing is mixed by code: for commonly used codes the provider often sits near or above typical national volumes — 99214 ranks in the 93th percentile nationally (598 claims) and 80053 ranks in the 93th percentile (891 claims) — while some chemotherapy and specialty drug codes are closer to typical or modest volumes (J0897 at the 65th percentile, 96413 at the 69th percentile). Conversely, certain chemotherapy-administration codes show unusually high relative volume: 96402 ranks in the 96th percentile and is flagged as "notably above typical national volume," indicating stronger-than-typical performance for subcutaneous/intramuscular hormonal antineoplastic administration.

Several drug-specific patterns stand out: high-volume low-paid injections appear in the mix (J1439 ferric carboxymaltose shows 14.3K claims but only $14.3K revenue and sits at the 12th percentile), while higher-priced oncology drugs like J1454 (fosnetupitant/palonosetron) and fulvestrant entries (J9395/J9393) contribute disproportionally by revenue even with fewer claims. This combination suggests the practice bills both frequently for low-unit-value infusion/support services and intermittently for higher-cost antiemetic and antineoplastic agents.

National comparator pool size and percentiles point to some narrow-market effects: J9393 is reported as ranking #3 of 4 providers nationally and is in the 33th percentile, indicating the national comparator set for that code is very small and percentile interpretations should be tempered by limited sample size. Similarly, several administration add-on and post-infusion codes (96417 at the 28th percentile, 96367 at the 26th percentile) fall below median national volumes, highlighting variability across specific chemotherapy-related services.

Operational implications for service line planning: the presence of frequent E/M visits (99214/99215) alongside core infusion codes (96413, 96365) implies an integrated clinic workflow where office-based management and on-site infusion are both revenue drivers. The provider’s revenue mix—high share from a small set of oncology codes plus substantial lab/CMP and CBC volumes (80053, 85025)—is consistent with a hematology/oncology outpatient practice that combines infusion treatment, routine monitoring labs, and symptom-management drug administration.

Tenure and stability: the NPI was enumerated on 2007-07-12 (~19 years ago), indicating long-standing Medicare enrollment which may reflect stable licensure and a sustained presence in the market; however, total lifetime Medicare revenue of $301K indicates a modest overall billing footprint relative to many national peers and suggests this is not a high-revenue outlier provider at the enterprise level.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

43 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0897	Injection, denosumab, 1 mg	4,080	$20	$73.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	600	$90	$54.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	250	$100	$24.9K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	170	$130	$22.5K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	60	$360	$20.4K
J9395	Injection, fulvestrant, 25 mg	1,630	$10	$14.7K
J1439	Injection, ferric carboxymaltose, 1 mg	14,250	$1	$14.3K
80053	The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel.	890	$10	$8.9K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	140	$50	$6.9K
J9393	Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg	450	$20	$6.8K

Showing 1–10 of 43

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 43 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maine Distribution

Chiara Battelli — 7 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maine

Full comparison — all codes billed, vs. state median

43 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0897	7	20	2,730	$20	$86.4K
J1439	10	10	24,750	$1	$32.2K
J3490	5	10	70	$390	$29.1K
96413	9	30	170	$100	$20.6K
J1454	5	10	60	$340	$18.3K
J9395	1	10	1,130	$10	$9.9K
99214	21	2,500	70	$70	$7.2K
J9393	1	10	450	$20	$6.9K
96365	9	30	90	$50	$5.6K
99215	38	780	30	$100	$4.8K

Showing 1–10 of 43

Related Providers

Other providers that share a Tax Identification Number (TIN) with Chiara Battelli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mercy Hospital	ME	General Acute Care Hospital	$0	$35.5M
Can Ilyas	ME	Hematology & Oncology Physician	$3.2M	$0
David Benton	ME	Hematology & Oncology Physician	$2.6M	$0
Matthew Dugan	ME	Hematology & Oncology Physician	$1.8M	$0
John Winters	ME	Hematology & Oncology Physician	$1.5M	$0
Maine Center For Cancer Medicine & Blood Disorders, P.A.	ME	Hematology & Oncology Physician	$0	$1.5M
Christian Thomas	ME	Hematology & Oncology Physician	$1.5M	$0
Devon Evans	ME	Hematology & Oncology Physician	$1.5M	$0
Brian Haney	ME	Hematology & Oncology Physician	$1.2M	$0
Yoko Fukuda	NH	Hematology & Oncology Physician	$945K	$0

Nearby Providers

Other providers in the same ZIP code as Chiara Battelli, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Creative Works	ME	Developmentally Disabled Services Day Training Agency	$0	$144.1M
Woodfords Family Services	ME	Community/Behavioral Health Agency	$0	$101.5M
Safe Residential Care, LLC	ME	Physical Disabilities Residential Treatment Facility	$0	$94.6M
3rivers, Inc.	ME	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$78.6M
Woodfords Family Services	ME	Community/Behavioral Health Agency	$0	$46.3M
Alliance Case Management	ME	Case Management Agency	$0	$17.8M
Woodfords Family Services	ME	In Home Supportive Care Agency	$0	$11.3M
Woodfords Family Services	ME	Case Management Agency	$0	$9.4M
Mas Medical Staffing Corporation	ME	Home Health Agency	$0	$8.1M
Maine Community Homecare	ME	In Home Supportive Care Agency	$0	$8.1M

Chiara Battelli — Billing Profile & Reimbursement Data

Sign up for Chiara Battelli — Billing Profile & Reimbursement Data policy alerts

Chiara Battelli — Billing Profile & Reimbursement Data

Sign up for Chiara Battelli — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References